(Q56832278)

1

0 references

L Dietz

2

0 references

H Nguyen

3

0 references

H Oberwittler

4

0 references

Rolf Aderjan

Clinical Pharmacology & Therapeutics

5

0 references

language of work or name

English

0 references

publication date

4 April 2007

0 references

published in

0 references

volume

82

0 references

page(s)

63-69

0 references

issue

1

0 references

cites work

The Metabolism of Δ9-Tetrahydrocannabinol and Related Cannabinoids in Man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

Hydroxylation of trans-Δ1-tetrahydrocannabinol by a hepatic microsomal monooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Metabolism of Δ1-tetrahydrocannabinol by the rat in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Identification in human urine of delta 9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

A comparison between the metabolism of Δ1-tetrahydrocannabinol by perfused lung and liver of rat and guinea-pig

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Delta-9-Tetrahydrocannabinol: Localization in Body Fat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

The Clinical Pharmacology and Dynamics of Marihuana Cigarette Smoking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021

Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor-Delta(9)-carboxy tetrahydrocannabinol glucuronide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100199

7 January 2021